发明名称 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
摘要 <p>Isolated nucleic acid molecules are disclosed, comprising an alphavirus nonstructural protein gene which, when operably incorporated into a recombinant alphavirus particle, eukaryotic layered vector initiation system, or RNA vector replicon, has a reduced level of vector-specific RNA synthesis, as compared to wild-type, and the same or greater level of proteins encoded by RNA transcribed from the viral junction region promoter, as compared to a wild-type recombinant alphavirus particle. Also disclosed are RNA vector replicons, alphavirus vector constructs, and eukaryotic layered vector initiation systems which contain the above-identified nucleic acid molecules. </p>
申请公布号 EP1997900(A3) 申请公布日期 2010.10.06
申请号 EP20080075018 申请日期 1997.04.04
申请人 NOVARTIS VACCINES AND DIAGNOSTICS, INC.;WASHINGTON UNIVERSITY 发明人 DUBENSKY, THOMAS W., JR.;POLO, JOHN M.;BELLI, BARBARA A.;SCHLESINGER, SONDRA;DRYGA, SERGEY A.;FROLOV, ILYA
分类号 C12N15/09;C12N15/86;A61K39/00;A61K48/00;C07K14/18;C12N5/10;C12N7/00;C12N7/04;C12N15/33;C12P21/00 主分类号 C12N15/09
代理机构 代理人
主权项
地址
您可能感兴趣的专利